StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific FDA 510 Medical Device/Diagnostic Clearances Granted by Quarter

FDA 510(k) Medical Device/Diagnostic Clearances Granted to Thermo Fisher (openFDA)

QuarterlyAnnualMonthly

Thermo Fisher Scientific FDA 510 Medical Device/Diagnostic Clearances Granted: 1 in Q3 2026, down 66.7% from a year earlier.

Latest, Q3 2026
1
Period ended Sep 30, 2026
Change on a year earlier
-66.7%
3 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
1
openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries

Where the Q3 2026 figure comes from

Source: openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗

Monthly, quarterly, and annual data series (2016–Q3 2026) aggregated directly from the openFDA database for all TMO subsidiaries (Thermo Fisher, Life Technologies, Phadia, Oxoid, Remel, One Lambda, Brammer, Affymetrix...).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFDA 510(k) Medical Device/Diagnostic Clearances Granted to Thermo Fisher (openFDA)Year on yearSource
Q3 2026Sep 30, 20261-66.7%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q2 2026Jun 30, 20261-83.3%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q1 2026Mar 31, 20260-100.0%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q4 2025Dec 31, 20252-71.4%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q3 2025Sep 30, 20253+200.0%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q2 2025Jun 30, 20256+500.0%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q1 2025Mar 31, 20254+100.0%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q4 2024Dec 31, 20247+75.0%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q3 2024Sep 30, 20241-80.0%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q2 2024Jun 30, 20241-66.7%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q1 2024Mar 31, 20242-33.3%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q4 2023Dec 31, 20234+33.3%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q3 2023Sep 30, 20235+66.7%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q2 2023Jun 30, 20233–openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q1 2023Mar 31, 20233–openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗
Q4 2022Dec 31, 20223-25.0%openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗

Breakdown

What makes up FDA 510 Medical Device/Diagnostic Clearances Granted

Cite this data

StockData. (2026). Thermo Fisher Scientific FDA 510 Medical Device/Diagnostic Clearances Granted, quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda-510k-company

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.